{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:56:28Z","timestamp":1773017788903,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA199334"],"award-info":[{"award-number":["U01CA199334"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Achieving cervical cancer (CC) elimination requires addressing disparities in CC burden for women living with HIV (WLHIV) and how disparities evolve in the context of antiretroviral therapy (ART) scale-up. To inform CC elimination for high HIV prevalence regions, we modeled the impact of HIV, HIV interventions, and CC interventions in KwaZulu-Natal, South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used 2 independently developed, dynamic compartmental transmission models of HIV and human papillomavirus (DRIVE and Policy1-Cervix-HIV) calibrated to KwaZulu-Natal. We simulated: a counterfactual without HIV but with observed CC screening and vaccination; and scenarios sequentially adding condom use and voluntary medical male circumcision (VMMC); HIV; observed HIV and CC interventions (status quo); achieving United Nations Programme on HIV\/AIDS HIV treatment targets; and achieving World Health Organization (WHO) CC elimination targets. The impact of each scenario was measured as the difference in CC incidence from the previous scenario. Results were reported from 2024 to 2124 as a range between the 2 models; CC elimination was WHO-defined as incidence &amp;lt;4\/100\u00a0000 women-years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For the status quo, CC incidence ranged from 61.30 to 78.96\/100\u00a0000 women-years in 2024, with the highest incidence among WLHIV (126.8-192.0\/100\u00a0000). HIV contributed an estimated 29.08-48.87 additional cases per 100\u00a0000. Neither model predicted elimination under status quo interventions, but achieving HIV treatment and CC elimination targets could reduce incidence to 1.42-6.25\/100\u00a0000 women-years in 2124.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HIV is associated with a population-level increase in CC incidence. However, scaling up ART coverage and CC interventions is expected to significantly reduce the burden of CC overall and among WLHIV. These conclusions are consistent between both models and strengthened by the comparative modeling approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaf364","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:53:36Z","timestamp":1765976016000},"page":"531-540","source":"Crossref","is-referenced-by-count":1,"title":["The impact of HIV on cervical cancer elimination in KwaZulu-Natal: a comparative modeling analysis"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7332-1480","authenticated-orcid":false,"given":"Christine L","family":"Hathaway","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA,","place":["United States"]},{"name":"University of Washington School of Medicine , Seattle, WA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-1449","authenticated-orcid":false,"given":"Michaela","family":"Hall","sequence":"additional","affiliation":[{"name":"Cancer Elimination Collaboration, Sydney School of Public Health, The University of Sydney , NSW,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1522-3489","authenticated-orcid":false,"given":"Dani\u00ebl","family":"de Bondt","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam Department of Public Health, Erasmus MC, , Rotterdam,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5627-8250","authenticated-orcid":false,"given":"Cara J","family":"Broshkevitch","sequence":"additional","affiliation":[{"name":"University of North Carolina-Chapel Hill Department of Epidemiology, , Chapel Hill, NC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0058-8513","authenticated-orcid":false,"given":"Darcy W","family":"Rao","sequence":"additional","affiliation":[{"name":"Bill and Melinda Gates Foundation , Seattle, WA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6720-8040","authenticated-orcid":false,"given":"Sydney","family":"Klein","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-3223","authenticated-orcid":false,"given":"Dorothy C","family":"Nyemba","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand Wits Reproductive Health and HIV Institute, , Johannesburg,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Travill","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand Wits Reproductive Health and HIV Institute, , Johannesburg,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-1019","authenticated-orcid":false,"given":"Sinead","family":"Delany-Moretlwe","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand Wits Reproductive Health and HIV Institute, , Johannesburg,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-6618","authenticated-orcid":false,"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[{"name":"Cancer Elimination Collaboration, Sydney School of Public Health, The University of Sydney , NSW,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hontelez","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam Department of Public Health, Erasmus MC, , Rotterdam,","place":["the Netherlands"]},{"name":"Heidelberg Institute of Global Health (HIGH), Heidelberg University Medical Center , Heidelberg,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1793-6003","authenticated-orcid":false,"given":"Ruanne V","family":"Barnabas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026030819565822600_djaf364-B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026030819565822600_djaf364-B2","first-page":"16","article-title":"Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus","volume":"27","author":"Mboumba Bouassa","year":"2017","journal-title":"Med Sante Trop"},{"key":"2026030819565822600_djaf364-B3","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026030819565822600_djaf364-B4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"2026030819565822600_djaf364-B5","doi-asserted-by":"crossref","first-page":"e0265488","DOI":"10.1371\/journal.pone.0265488","article-title":"Increase in HIV viral suppression in KwaZulu-Natal, South Africa: community-based cross sectional surveys 2018 and 2013. What remains to be done?","volume":"17","author":"Conan","year":"2022","journal-title":"PLoS One"},{"key":"2026030819565822600_djaf364-B6","volume-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","author":"WHO","year":"2020"},{"key":"2026030819565822600_djaf364-B7","volume-title":"Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention","author":"WHO","year":"2021","edition":"2nd ed"},{"key":"2026030819565822600_djaf364-B8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/s41591-023-02601-3","article-title":"Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV","volume":"29","author":"Hall","year":"2023","journal-title":"Nat Med"},{"key":"2026030819565822600_djaf364-B9","volume-title":"Cervical Cancer Prevention and Control Policy"},{"key":"2026030819565822600_djaf364-B10","volume-title":"Understanding Fast-Track: Accelerating Action to End the AIDS Epidemic by 2030","author":"UNAIDS","year":"2015"},{"key":"2026030819565822600_djaf364-B11","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"key":"2026030819565822600_djaf364-B12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12981-017-0167-6","article-title":"The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field","volume":"14","author":"Prodger","year":"2017","journal-title":"AIDS Res Therapy"},{"key":"2026030819565822600_djaf364-B13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsagu\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"2026030819565822600_djaf364-B14","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"2026030819565822600_djaf364-B15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0969141314522454","article-title":"Condom use in prevention of human papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies","volume":"21","author":"Lam","year":"2014","journal-title":"J Med Screen"},{"key":"2026030819565822600_djaf364-B16","doi-asserted-by":"crossref","first-page":"e25790","DOI":"10.1002\/jia2.25790","article-title":"Refining global HIV estimates for decision-making: advances in analytic and modelling methods used by the Joint United Nations Programme on HIV\/AIDS","volume":"24(Suppl 5)","author":"Maheu-Giroux","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"2026030819565822600_djaf364-B17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/QAD.0000000000002221","article-title":"Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa","volume":"33","author":"Joseph Davey","year":"2019","journal-title":"AIDS"},{"key":"2026030819565822600_djaf364-B18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"2026030819565822600_djaf364-B19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"key":"2026030819565822600_djaf364-B20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M19-2797","article-title":"Comparative modeling to inform health policy decisions: a step forward","volume":"171","author":"Kim","year":"2019","journal-title":"Ann Intern Med"},{"key":"2026030819565822600_djaf364-B21","doi-asserted-by":"crossref","first-page":"101306","DOI":"10.1016\/j.eclinm.2022.101306","article-title":"Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: a mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence","volume":"45","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026030819565822600_djaf364-B22","doi-asserted-by":"crossref","first-page":"e26021","DOI":"10.1002\/jia2.26021","article-title":"Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa","volume":"25","author":"Rao","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"2026030819565822600_djaf364-B23","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1016\/j.vaccine.2018.02.023","article-title":"Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa","volume":"36","author":"Tan","year":"2018","journal-title":"Vaccine"},{"key":"2026030819565822600_djaf364-B24","doi-asserted-by":"crossref","first-page":"1382599","DOI":"10.3389\/fonc.2024.1382599","article-title":"Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic","volume":"14","author":"Tran","year":"2024","journal-title":"Front Oncol"},{"key":"2026030819565822600_djaf364-B25","doi-asserted-by":"crossref","first-page":"e0231388","DOI":"10.1371\/journal.pone.0231388","article-title":"The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: a modelling study","volume":"15","author":"Hall","year":"2020","journal-title":"PLoS One"},{"key":"2026030819565822600_djaf364-B26","volume-title":"The Fifth South African National HIV Prevalence, Incidence, Behaviour and Communications Survey, 2017","author":"Simbayi","year":"2019"},{"key":"2026030819565822600_djaf364-B27","doi-asserted-by":"crossref","first-page":"e1914378","DOI":"10.1001\/jamanetworkopen.2019.14378","article-title":"Trends in HIV prevention, treatment, and incidence in a hyperendemic area of KwaZulu-Natal, South Africa","volume":"2","author":"Kharsany","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026030819565822600_djaf364-B28","author":"UNAIDS"},{"key":"2026030819565822600_djaf364-B29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAD.0000000000001340","article-title":"The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets","volume":"31","author":"Takuva","year":"2017","journal-title":"AIDS"},{"key":"2026030819565822600_djaf364-B30","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e328362e832","article-title":"Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment","volume":"27","author":"Zaidi","year":"2013","journal-title":"AIDS"},{"key":"2026030819565822600_djaf364-B31","author":"WHO\/UNICEF","year":"2020"},{"key":"2026030819565822600_djaf364-B32","volume-title":"South Africa Demographic and Health Survey 2016","author":"National Department of Health (NDoH), Statistics South Africa (Stats SA), South African Medical Research Council (SAMRC), and ICF","year":"2019"},{"key":"2026030819565822600_djaf364-B33","first-page":"241","volume-title":"World Population Prospects: The 2015 Revision","author":"United Nations, Department of Economic and Social Affairs, Population Division.","year":"2017"},{"key":"2026030819565822600_djaf364-B34","doi-asserted-by":"crossref","first-page":"e0301997","DOI":"10.1371\/journal.pone.0301997","article-title":"Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: a modeling analysis","volume":"19","author":"Broshkevitch","year":"2024","journal-title":"PLoS One"},{"key":"2026030819565822600_djaf364-B35","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.33716","article-title":"Modelling the impact of prevention strategies on cervical cancer incidence in South Africa","volume":"149","author":"van Schalkwyk","year":"2021","journal-title":"Int J Cancer"},{"key":"2026030819565822600_djaf364-B36","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2026030819565822600_djaf364-B37","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","article-title":"HIV pre-exposure prophylaxis: scaling up for impact now and in the future","volume":"6","author":"Bavinton","year":"2021","journal-title":"Lancet Public Health"},{"key":"2026030819565822600_djaf364-B38","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","article-title":"Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results","volume":"29","author":"Barnabas","year":"2023","journal-title":"Nat Med"},{"key":"2026030819565822600_djaf364-B39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnci\/djaa011","article-title":"Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Kreimer","year":"2020","journal-title":"J Natl Cancer Inst"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf364\/66015350\/djaf364.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/3\/531\/66015350\/djaf364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/3\/531\/66015350\/djaf364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:57:09Z","timestamp":1773014229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/3\/531\/8383913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,18]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf364","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,18]]}}}